Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 14.00
-0.66 (-4.50%)
Aug 3, 2026, 1:44 PM CET
Genfit Market Cap
Genfit has a market cap or net worth of €733.36 million as of August 3, 2026. Its market cap has increased by 317.92% in one year.
Market Cap
733.36M
Enterprise Value
782.95M
Revenue
70.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€14.00
ChartMarket Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 733.36M, an increase of 402.07%. That is a compound annual growth rate of 8.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 733.36M | 179.72% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.71B |
| MedinCell | 931.35M |
| Inventiva | 897.86M |
| DBV Technologies | 695.40M |
| Valneva SE | 407.36M |
| Valerio Therapeutics Société anonyme | 370.09M |
| Transgene | 194.73M |
| Cellectis | 179.18M |